• Jan 30, 2018
    The Department of Workers' Comp (DWC) came out with new proposed rules on compounded medications last week. The proposed rules change the definition of the closed formulary to exclude any prescription drug created through compounding, and to require preauthorization for all prescription drugs created through compounding. If adopted, these amendments become effective July 1, 2018.
  • Oct 18, 2017
    Under a state of emergency declared by Gov. Edmund G. Brown due to multiple fires in Napa, Sonoma and Yuba Counties (https://www.gov.ca.gov/home.php), the California State Board of Pharmacy reminds pharmacists and pharmacies about pharmacy law provisions that can be of assistance in caring for patients displaced by the emergency relocations.
  • Aug 21, 2017
    As required by AB 602 (Bonta, Chapter 139, Statutes of 2017), a list of names of authorized distributors of nonprescription diabetes test devices is now posted on the California State Board of Pharmacy website.
  • Jul 07, 2017
    IPC has been working closely with other Pennsylvania pharmacy industry stakeholders, including the Pennsylvania Pharmacists Association (PPA), to monitor Pennsylvania Medicaid's development of a new federally mandated fee-for-service (FFS) prescription reimbursement formula designed to reflect transparent "true cost" to provide Medicaid patients with access to their prescription drug benefit.
  • Jul 06, 2017
    IPC has learned that the final version of the Ohio State Annual Appropriations Act signed into law by Ohio Governor John Kasich (R) contained the Senate version which allows Medicaid to move forward with its proposed four (4) tiered, volume based dispensing fee rather than the House proposed flat fee of $10.49.
  • Jul 06, 2017
    California PBM Transparency Measure Passes Key Senate Committee. Yesterday, July 5th, the California Senate Health Committee heard Assembly Bill 315 (AB 315). The legislation passed in the House with tremendous support last month and would ensure patients gain necessary authority over their own healthcare decisions, including their treatments and prescriptions, while Pharmacies are afforded much needed protections against the Pharmacy Benefit Managers (PBMs).